Location: San Francisco, CA
CIK: 0001844645 · Show all filings
Period: Q3 2025 (← Previous) (Next →)
Filing Date: Nov 13, 2025
Total Value: $173M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PCVX | VAXCYTE INC | 1,372,425 | $49.43M | 28.6% | $38.62 | -14.2% | COM | 92243G108 |
| OCS | OCULIS HOLDING AG | 2,300,774 | $40.45M | 23.4% | $12.64 | +40.3% | ORDINARY SHARES | H5870P102 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 2,120,508 | $39.97M | 23.1% | $11.27 | +40.0% | COM | 03969K108 |
| ZBIO | ZENAS BIOPHARMA INC | 779,045 | $17.29M | 10.0% | $17.27 | -5.7% | COM | 98937L105 |
| TRVI | TREVI THERAPEUTICS INC | 1,256,782 | $11.5M | 6.6% | $6.33 | +18.4% | COM | 89532M101 |
| IMNM | IMMUNOME INC | 502,512 | $5.884M | 3.4% | $9.95 | 0.0% | COM | 45257U108 |
| BIOA | BIOAGE LABS INC | 653,374 | $3.842M | 2.2% | $19.50 | -76.0% | COM | 09077V100 |
| RXRX | RECURSION PHARMACEUTICALS IN | 595,518 | $2.906M | 1.7% | $6.72 | -21.9% | CL A | 75629V104 |
| — | RALLYBIO CORP | 2,404,644 | $1.2M | 0.7% | $16.97 | — | COM | 75120L100 |
| BOLT | BOLT BIOTHERAPEUTICS INC | 94,573 | $503K | 0.3% | $6.62 | -16.2% | COM NEW | 097702203 |